Shares of Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$13.90 and traded as low as C$12.65. Cipher Pharmaceuticals shares last traded at C$12.65, with a volume of 18,572 shares traded.
Analyst Ratings Changes
Separately, Stifel Nicolaus cut their price objective on shares of Cipher Pharmaceuticals from C$19.00 to C$17.00 in a research report on Monday, November 11th.
Get Our Latest Stock Analysis on CPH
Cipher Pharmaceuticals Stock Performance
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.
Featured Articles
- Five stocks we like better than Cipher Pharmaceuticals
- Insider Trades May Not Tell You What You Think
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Find Undervalued Stocks
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to Read Stock Charts for Beginners
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.